Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-01Clinical Trial Update: A Study of Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C and Compensated Cirrhosis [Phase 2]
Phase 2 study evaluating ritonavir-boosted danoprevir with RO5024048 in null responders or treatment-naïve chronic hepatitis C patients with…
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Effect of Camel Milk on Chronic Hepatitis C [Phase 2]
A Phase 2 clinical trial evaluating the effect of camel milk on chronic hepatitis C has completed. The study was sponsored by Mashhad Univer…
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure. [Phase 4]
Phase 4 study of PEGASYS (Peginterferon alfa-2a) in patients with chronic hepatitis C and chronic kidney disease has completed, and results …
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 8 Weeks in Subjects With Chronic Genotype 1 HCV and HIV-1 Co-infection [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of an 8-week fixed-dose combination of ledipasvir/sofosbuvir in adults with chronic genot…
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus [Phase 1, Phase 2]
Open-label Phase 1/2 trial of telaprevir in combination with peginterferon alfa-2b and ribavirin in pediatric patients with Hepatitis C was …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: The Effect of High Dose Vitamin C on the Liver Function in Chronic Hepatitis Patients [Phase 4]
Phase 4 clinical trial evaluating the effect of high-dose vitamin C on liver function in patients with chronic hepatitis; results were poste…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Influence of Ribavirin on the Initial Virological Response in Treatment Naïve Patients With Hepatitis C Genotype 1 Infection [Phase 2]
A Phase 2 trial evaluating the effect of ribavirin on initial virological response in treatment-naïve patients with hepatitis C genotype 1 i…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: A Study to Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV) [Phase 2]
Phase 2 study evaluating paritaprevir/ritonavir with ombitasvir, with and without ribavirin, in treatment-naïve patients with genotype 1–3 c…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus (HCV) Genotype (GT)1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062) [Phase 3]
Phase 3 trial evaluating the combination of grazoprevir and elbasvir for treatment-naïve chronic hepatitis C patients on opiate substitution…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: A Study of PEGASYS (Peginterferon Alfa-2a) Plus Ribavirin in Patients With Chronic Hepatitis C (CHC), Genotype 2 or 3 [Phase 4]
Phase 4 study of Peginterferon alfa-2a plus ribavirin in chronic hepatitis C (genotype 2/3) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC). [Phase 4]
Phase 4 trial evaluating Pegasys (peginterferon alfa-2a) in combination with Copegus (ribavirin) in interferon-naive patients with chronic h…
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation [Phase 3]
A Phase 3 trial studying telaprevir for genotype 1 hepatitis C infection in liver transplant recipients has completed, reporting efficacy an…
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis [Phase 3]
Phase 3 trial evaluating Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in adults with genotype 1b chronic hepatitis C and compensated cirr…
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: A Study to Evaluate Chronic Hepatitis C Virus (HCV) Infection in Cirrhotic Adults With Genotype 1b (GT1b) Infection [Phase 3]
Phase 3 trial in cirrhotic adults with genotype 1b chronic hepatitis C infection has completed and results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
A Stanford-led clinical trial investigating viral and host factors associated with HBV-related hepatocellular carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Safety and Efficacy of Boceprevir in Asia Pacific Participants With Chronic Hepatitis C Genotype 1 (P07063) [Phase 3]
Phase 3 trial update on safety and efficacy of boceprevir in Asia Pacific participants with chronic hepatitis C genotype 1 completed; result…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C [Phase 3]
Phase 3 trial of alisporivir combined with pegylated interferon and ribavirin in protease inhibitor-treatment-failure patients with chronic …
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Safety Study of INX-08189, Pharmacokinetic and Pharmacodynamic With Ribavirin and Food Effect Study, in Chronically-infected Genotype 1 Hepatitis C Virus, Treatment-naïve Subjects [Phase 1, Phase 2]
This ClinicalTrials.gov entry reports a Phase 1/2 safety, pharmacokinetic, and pharmacodynamic study of INX-08189 with ribavirin in treatmen…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: A Study of Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) [Phase 4]
Phase 4 study evaluating the relationship between IL28B expression and sustained virological response in treatment-naïve patients with chron…
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir
A clinical trial update examining factors that predict treatment failure in chronic hepatitis C patients treated with telaprevir, identifyin…
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1. [Phase 4]
This completed Phase 4 trial studied PEGASYS (peginterferon alfa-2a) and COPEGUS (ribavirin) in treatment-naive patients with chronic hepati…
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: POTENTE Study: A Study of Early Virological Response in Naive Patients With Chronic Hepatitis C, Genotype 2 or 3, Treated With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin).
This trial update reports the POTENTE study evaluating early virological response in treatment-naive chronic hepatitis C patients with genot…
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant [Phase 2]
Phase 2 trial evaluating a fixed-dose combination of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients with advanced live…
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Endothelial Dysfunction and Subclinical Atheromatosis in Chronic HCV Infection. Response to DAA Agents. [Phase 4]
Phase 4 clinical trial update examining endothelial dysfunction and subclinical atheromatosis in chronic hepatitis C infection and the effec…
-
CLINICAL_TRIALS trial_result · 2016-06-15Clinical Trial Update: PROPHESYS 1: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Virus (HCV)Treated With Pegasys (Peginterferon Alfa-2a)
The PROPHESYS 1 study update describes predictors of response in treatment-naïve patients with chronic hepatitis C virus infection treated w…